Sweden
Probi AB is a global leader in probiotics, specializing in researching, manufacturing, and delivering probiotics for supplements and functional food. Established in 1991 at Sweden’s Lund University, Probi has since expanded its operations to more than 40 markets, with a strong focus on Health Care and Manufacturing industries. The company holds an impressive portfolio of more than 400 patents globally, demonstrating its commitment to innovation and leadership in the probiotics space.
Probi®'s dedication to managing stable, live bacteria from R&D through the manufacturing process ensures high-quality products with documented health benefits. The company's health concepts, formulations, and formats are backed by robust clinical documentation, contributing to its credibility and trust in the market.
As a probiotics pioneer, Probi AB stands out with its passion for people and its mission to make the health-enhancing benefits of probiotics accessible worldwide. While specific information about the last investment and investors is currently unavailable, Probi's strong track record and global presence position it as an attractive potential for venture capital investment in the health and wellness sector.
